Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xortx Therapeutics Inc (XRTX)

Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xortx Therapeutics Inc 3710 - 33RD STREET NW ALBERTA A1 T2L 2M1 CAN

www.xortx.com Employees: 17 P: 403-455-7727 F: 403-260-3501

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

XORTX Therapeutics Inc. is a pharmaceutical therapeutics company. It focused on developing therapies to treat progressive kidney disease. XORTX Therapeutics Inc. is based in CALGARY, Alberta.

Key Statistics

Overview:

Market Capitalization, $K 4,021
Enterprise Value, $K 1,551
Shares Outstanding, K 6,962
Float, K 6,482
% Float 93.10%
Short Interest, K 36
Short Float 0.51%
Days to Cover 1.10
Short Volume Ratio 0.68
% of Insider Shareholders 6.90%
% of Institutional Shareholders 0.23%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -3,310 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -650 K
EBIT, $ -3,130 K
EBITDA, $ -3,010 K

Growth:

1-Year Return -46.23%
3-Year Return -91.50%
5-Year Return -97.92%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.13 on 11/14/25
Next Earnings Date 03/24/26
Earnings Per Share ttm -0.47
EPS Growth vs. Prev Qtr 31.58%
EPS Growth vs. Prev Year 35.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 01/31/14
Dividend Payout Ratio 0.00%
Most Recent Split 1-9 on 11/14/23

XRTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -77.08%
Return-on-Assets % -59.12%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.54
Book Value/Share 0.38
Interest Coverage -0.13
60-Month Beta 0.49
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar